Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study

Methylphenidate (MPH) is a first line drug for attention-deficit/hyperactivity disorder (ADHD), yet the neuronal mechanisms underlying the condition and the treatment are still not fully understood. Previous EEG studies on the effect of MPH in ADHD found changes in evoked response potential (ERP) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubinson, Mica, Horowitz, Itai, Naim-Feil, Jodie, Gothelf, Doron, Levit-Binnun, Nava, Moses, Elisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544236/
https://www.ncbi.nlm.nih.gov/pubmed/31150439
http://dx.doi.org/10.1371/journal.pone.0217383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544236/
https://www.ncbi.nlm.nih.gov/pubmed/31150439
http://dx.doi.org/10.1371/journal.pone.0217383

Ejemplares similares